Cargando…

Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease

Alzheimer’s disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the foref...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnst, Nikita, Redolfi, Nelly, Lia, Annamaria, Bedetta, Martina, Greotti, Elisa, Pizzo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775979/
https://www.ncbi.nlm.nih.gov/pubmed/36551781
http://dx.doi.org/10.3390/biomedicines10123025
_version_ 1784855765615378432
author Arnst, Nikita
Redolfi, Nelly
Lia, Annamaria
Bedetta, Martina
Greotti, Elisa
Pizzo, Paola
author_facet Arnst, Nikita
Redolfi, Nelly
Lia, Annamaria
Bedetta, Martina
Greotti, Elisa
Pizzo, Paola
author_sort Arnst, Nikita
collection PubMed
description Alzheimer’s disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the forefront the “calcium (Ca(2+)) hypothesis” as a key AD pathogenic pathway, impacting neuronal, astrocyte and microglial function. In this review, we focused on mitochondrial Ca(2+) alterations in AD, their causes and bioenergetic consequences in neuronal and glial cells, summarizing the possible mechanisms linking detrimental mitochondrial Ca(2+) signals to neuronal death in different experimental AD models.
format Online
Article
Text
id pubmed-9775979
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97759792022-12-23 Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease Arnst, Nikita Redolfi, Nelly Lia, Annamaria Bedetta, Martina Greotti, Elisa Pizzo, Paola Biomedicines Review Alzheimer’s disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the forefront the “calcium (Ca(2+)) hypothesis” as a key AD pathogenic pathway, impacting neuronal, astrocyte and microglial function. In this review, we focused on mitochondrial Ca(2+) alterations in AD, their causes and bioenergetic consequences in neuronal and glial cells, summarizing the possible mechanisms linking detrimental mitochondrial Ca(2+) signals to neuronal death in different experimental AD models. MDPI 2022-11-24 /pmc/articles/PMC9775979/ /pubmed/36551781 http://dx.doi.org/10.3390/biomedicines10123025 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Arnst, Nikita
Redolfi, Nelly
Lia, Annamaria
Bedetta, Martina
Greotti, Elisa
Pizzo, Paola
Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
title Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
title_full Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
title_fullStr Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
title_full_unstemmed Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
title_short Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
title_sort mitochondrial ca(2+) signaling and bioenergetics in alzheimer’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775979/
https://www.ncbi.nlm.nih.gov/pubmed/36551781
http://dx.doi.org/10.3390/biomedicines10123025
work_keys_str_mv AT arnstnikita mitochondrialca2signalingandbioenergeticsinalzheimersdisease
AT redolfinelly mitochondrialca2signalingandbioenergeticsinalzheimersdisease
AT liaannamaria mitochondrialca2signalingandbioenergeticsinalzheimersdisease
AT bedettamartina mitochondrialca2signalingandbioenergeticsinalzheimersdisease
AT greottielisa mitochondrialca2signalingandbioenergeticsinalzheimersdisease
AT pizzopaola mitochondrialca2signalingandbioenergeticsinalzheimersdisease